Nizar Hami

1.4k total citations
6 papers, 234 citations indexed

About

Nizar Hami is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Nizar Hami has authored 6 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Nizar Hami's work include Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Nizar Hami is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Nizar Hami collaborates with scholars based in Netherlands, Germany and United Kingdom. Nizar Hami's co-authors include Wigard P. Kloosterman, Hans Clevers, Kadi Lõhmussaar, Paul van Diest, Edwin Cuppen, Jose Espejo Valle-Inclán, Luan Nguyen, Petronella O. Witteveen, Celien P.H. Vreuls and Geertruida N. Jonges and has published in prestigious journals such as Genome Research, Cell Reports and Oncotarget.

In The Last Decade

Nizar Hami

5 papers receiving 233 citations

Peers

Countries citing papers authored by Nizar Hami

Since Specialization

Citations

This map shows the geographic impact of Nizar Hami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nizar Hami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nizar Hami more than expected).

Fields of papers citing papers by Nizar Hami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nizar Hami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nizar Hami. The network helps show where Nizar Hami may publish in the future.

Co-authorship network of co-authors of Nizar Hami

This figure shows the co-authorship network connecting the top 25 collaborators of Nizar Hami. A scholar is included among the top collaborators of Nizar Hami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nizar Hami. Nizar Hami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling 2025 ·Genome Research ·Li‐Ting Chen, Myrthe Jager, (unknown), (unknown), Tom van den Ende, Willem Vanderlinden, (unknown), Marc Pagès-Gallego, Ymke van der Pol, Nicolle Besselink, Norbert Moldován, Nizar Hami, Wigard P. Kloosterman, Hanneke W. M. van Laarhoven, Florent Moulière, Ronald P. Zweemer, Jan Lipfert, Sarah Derks, Alessio Marcozzi, Jeroen de Ridder	3
2	The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients 2025 ·Cancers ·(unknown), Nizar Hami, Hans W. Nijman, Jurgen M.J. Piek, Luc R.C.W. van Lonkhuijzen, Eva Maria Roes, Ward Hofhuis, Christianne Lok, Cor D. de Kroon, Eelke Gort, Petronella O. Witteveen, Ronald P. Zweemer, Jolijn W. Groeneweg	0
3	Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors 2024 ·Molecular Cancer Therapeutics ·(unknown), Nizar Hami, Sander Mertens, Hans W. Nijman, Luc R.C.W. van Lonkhuijzen, Eva Maria Roes, Christianne Lok, Cor D. de Kroon, Jurgen M.J. Piek, Ward Hofhuis, Hugo J.G. Snippert, Jolijn W. Groeneweg, Petronella O. Witteveen, Ronald P. Zweemer	1
4	Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity 2020 ·Molecular Cancer Research ·(unknown), (unknown), Markus J. van Roosmalen, Nizar Hami, Ingrid Verlaan-Klink, Harmjan R. Vos, Robert M. van Es, Marco J. Koudijs, Emile E. Voest, Hugo J.G. Snippert, Wigard P. Kloosterman	11
5	Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses 2020 ·Cell Reports ·Chris J. de Witte, Jose Espejo Valle-Inclán, Nizar Hami, Kadi Lõhmussaar, Oded Kopper, Celien P.H. Vreuls, Geertruida N. Jonges, Paul van Diest, Luan Nguyen, Hans Clevers, Wigard P. Kloosterman, Edwin Cuppen, (unknown), Ronald P. Zweemer, Petronella O. Witteveen, Ellen Stelloo	203
6	CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition 2019 ·Oncotarget ·(unknown), Nizar Hami, (unknown), (unknown), Johannes L. Bos, Hugo J.G. Snippert	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact